Emma Rathbone

715 total citations
11 papers, 481 citations indexed

About

Emma Rathbone is a scholar working on Oncology, Radiology, Nuclear Medicine and Imaging and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Emma Rathbone has authored 11 papers receiving a total of 481 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Oncology, 7 papers in Radiology, Nuclear Medicine and Imaging and 5 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Emma Rathbone's work include Bone health and treatments (7 papers), Radiopharmaceutical Chemistry and Applications (6 papers) and Prostate Cancer Treatment and Research (4 papers). Emma Rathbone is often cited by papers focused on Bone health and treatments (7 papers), Radiopharmaceutical Chemistry and Applications (6 papers) and Prostate Cancer Treatment and Research (4 papers). Emma Rathbone collaborates with scholars based in United Kingdom, Ireland and Australia. Emma Rathbone's co-authors include Robert E. Coleman, Janet E. Brown, David Cameron, Helen Marshall, Richard H. Bell, Roger Burkinshaw, Samantha Hinsley, Caroline Wilson, David Dodwell and Maccon Keane and has published in prestigious journals such as Journal of Clinical Oncology, JNCI Journal of the National Cancer Institute and The Lancet Oncology.

In The Last Decade

Emma Rathbone

11 papers receiving 474 citations

Peers

Countries citing papers authored by Emma Rathbone

Since Specialization

Citations

This map shows the geographic impact of Emma Rathbone's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Emma Rathbone with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Emma Rathbone more than expected).

Fields of papers citing papers by Emma Rathbone

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Emma Rathbone. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Emma Rathbone. The network helps show where Emma Rathbone may publish in the future.

Co-authorship network of co-authors of Emma Rathbone

This figure shows the co-authorship network connecting the top 25 collaborators of Emma Rathbone. A scholar is included among the top collaborators of Emma Rathbone based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Emma Rathbone. Emma Rathbone is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

11 of 11 papers shown

#	Work	Indexed citations
1	Prolonged bone health benefits for breast cancer patients following adjuvant bisphosphonate therapy: the BoHFAB study 2024 ·Journal of Bone and Mineral Research ·Janet E. Brown, Margaret Paggiosi, Emma Rathbone, Walter M. Gregory, (unknown), Omar Din, Eugène McCloskey, David Dodwell, David Cameron, Richard Eastell, Robert E. Coleman	3
2	A phase IB and randomised phase IIA trial of CApecitabine plus Radium-223 (Xofigo™) in breast cancer patients with BONe metastases: CARBON trial results 2022 ·Journal of bone oncology ·Matthew Winter, Rob Coleman, (unknown), Carlo Palmieri, Chris Twelves, Sacha J. Howell, Iain R. Macpherson, Caroline Wilson, (unknown), Jacqui Gath, Christine L. Taylor, Richard Eastell, (unknown), Sarah Brown, Emma Rathbone, Janet E. Brown	9
3	CApecitabine plus Radium-223 (Xofigo™) in breast cancer patients with BONe metastases (CARBON): study protocol for a phase IB/IIA randomised controlled trial 2020 ·Trials ·Rob Coleman, Janet E. Brown, Emma Rathbone, Louise Flanagan, (unknown), (unknown), Sacha J. Howell, Chris Twelves, Carlo Palmieri, Anjana Anand, Iain R. Macpherson, Sarah Brown	11
4	Early experience of maintenance durvalumab post chemoradiation (CRT) in stage III non-small cell lung cancer (NSCLC) across West Yorkshire network: from Expanded Access Programme (EAP) to routine clinical use 2020 ·Lung Cancer ·Prantesh Jain, (unknown), K. Clarke, K. Franks, (unknown), (unknown), (unknown), Anne‐Marie Conn, Nicholas R. Brown, Emma Rathbone	7
5	Cerebrospinal fluid immunoglobulin light chain ratios predict disease progression in multiple sclerosis 2018 ·Journal of Neurology Neurosurgery & Psychiatry ·Emma Rathbone, (unknown), James L. Kinsella, Antony R. Parker, Ghaniah Hassan‐Smith, Michael R. Douglas, John Curnow	31
6	CCR6+ Th cells in the cerebrospinal fluid of persons with multiple sclerosis are dominated by pathogenic non-classic Th1 cells and GM-CSF-only-secreting Th cells 2017 ·Brain Behavior and Immunity ·(unknown), (unknown), Seema Kalra, Ghaniah Hassan‐Smith, Emma Rathbone, Marlis R. Douglas, John Curnow	58
7	Associations Between Serum Bone Biomarkers in Early Breast Cancer and Development of Bone Metastasis: Results From the AZURE (BIG01/04) Trial 2017 ·JNCI Journal of the National Cancer Institute ·Janet E. Brown, Emma Rathbone, Samantha Hinsley, Walter M. Gregory, Fatma Gossiel, Helen Marshall, Roger Burkinshaw, (unknown), (unknown), Gianfilippo Bertelli, (unknown), Angela Bowman, Andrew M. Hanby, Richard H. Bell, David Cameron, Robert E. Coleman	31
8	Adjuvant zoledronic acid in patients with early breast cancer: final efficacy analysis of the AZURE (BIG 01/04) randomised open-label phase 3 trial 2014 ·The Lancet Oncology ·Robert E. Coleman, David Cameron, David Dodwell, Richard H. Bell, Caroline Wilson, Emma Rathbone, Maccon Keane, Miguel Gil‐Gil, Roger Burkinshaw, Robert Grieve, Peter Barrett‐Lee, Diana Ritchie, (unknown), Samantha Hinsley, Helen Marshall	202
9	Management of cancer treatment-induced bone loss 2013 ·Nature Reviews Rheumatology ·Robert E. Coleman, Emma Rathbone, Janet E. Brown	68
10	Osteonecrosis of the Jaw and Oral Health–Related Quality of Life After Adjuvant Zoledronic Acid: An Adjuvant Zoledronic Acid to Reduce Recurrence Trial Subprotocol (BIG01/04) 2013 ·Journal of Clinical Oncology ·Emma Rathbone, Janet E. Brown, Helen Marshall, Michelle Collinson, (unknown), (unknown), David Cameron, Richard H. Bell, (unknown), R. K. Agrawal, R. Jyothirmayi, Prabir Chakraborti, (unknown), Robert E. Coleman	34
11	Visual acuity in young elite motorsport athletes: A preliminary report 2010 ·Physical Therapy in Sport ·Anthony G. Schneiders, S. John Sullivan, Emma Rathbone, (unknown), (unknown), (unknown)	27

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact